AMR Sept Banner v2

ASM Attends UN General Assembly

ASM President, Susan Sharp, Ph.D., joined global leaders at the United Nations General Assembly in New York today in a historical meeting to focus on the commitment to fight AMR.
Read

UN General Assembly Focuses on AMR

Leaders at the UN General Assembly draft a plan for coordinated, cross-cutting efforts to improve the current state of AMR.
Read

Superbugs are a 'Fundamental Threat'

If antibiotics were telephones, we would still be calling each other using clunky rotary dials and copper lines," Stefano Bertuzzi, CEO of ASM, told NBC News.
Read
Become a member today!
JOIN ASM
Submit Abstracts for Biothreats 2017
SUBMIT
Antibacterial Development Conference
REGISTER

lichten michaelMichael Lichten uses the budding yeast Saccharomyces cerevisiae as a model organism in which meiotic recombination and DNA damage repair can be studied at molecular, chromosomal, and whole-genome levels. His current research focuses on three interrelated topics. The first involves factors that determine where and when meiotic DSBs form; the second involves factors and mechanisms that regulate choice of a partner for DSB repair; the third involves the factors that catalyze and regulate recombination intermediate formation and resolution. Although his primary focus is on the recombination events that occur during meiosis, his work also addresses mechanisms and regulation of recombination and repair events that occur during the mitotic cell cycle.

 

Website: http://ccr.cancer.gov/staff/staff.asp?profileid=5611

TPL_asm2013_SEARCH

91118